Cargando…
Adjunctive corticosteroids may be associated with better outcome for non-HIV Pneumocystis pneumonia with respiratory failure: a systemic review and meta-analysis of observational studies
BACKGROUND: Evidence supporting corticosteroids adjunctive treatment (CAT) for Pneumocystis jirovecii pneumonia (PCP) in non-HIV patients is highly controversial. We aimed to systematically review the literature and perform a meta-analysis of available data relating to the effect of CAT on mortality...
Autores principales: | Ding, Lin, Huang, Huixue, Wang, Heyan, He, Hangyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083987/ https://www.ncbi.nlm.nih.gov/pubmed/32198645 http://dx.doi.org/10.1186/s13613-020-00649-9 |
Ejemplares similares
-
A 21-Day of Adjunctive Corticosteroid Use May Not Be Necessary for HIV-1-Infected Pneumocystis Pneumonia with Moderate and Severe Disease
por: Shibata, Satoshi, et al.
Publicado: (2015) -
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials
por: Briel, Matthias, et al.
Publicado: (2005) -
Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia
por: Lemiale, Virginie, et al.
Publicado: (2013) -
Immune Modulation as Adjunctive Therapy for Pneumocystis pneumonia
por: Wang, Jing, et al.
Publicado: (2011) -
Adjunctive corticosteroid treatment for organizing pneumonia in COVID-19 patients with persistent respiratory failure
por: Segala, Francesco Vladimiro, et al.
Publicado: (2021)